163 related articles for article (PubMed ID: 10720749)
1. Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases.
Burchell B; Soars M; Monaghan G; Cassidy A; Smith D; Ethell B
Toxicol Lett; 2000 Mar; 112-113():333-40. PubMed ID: 10720749
[TBL] [Abstract][Full Text] [Related]
2. Combined polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome.
Peters WH; te Morsche RH; Roelofs HM
J Hepatol; 2003 Jan; 38(1):3-8. PubMed ID: 12480553
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome.
Monaghan G; Ryan M; Seddon R; Hume R; Burchell B
Lancet; 1996 Mar; 347(9001):578-81. PubMed ID: 8596320
[TBL] [Abstract][Full Text] [Related]
4. TATA-box mutant in the promoter of the uridine diphosphate glucuronosyltransferase gene in Italian patients with Gilbert's syndrome.
Sampietro M; Lupica L; Perrero L; Romano R; Molteni V; Fiorelli G
Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):194-8. PubMed ID: 9675658
[TBL] [Abstract][Full Text] [Related]
5. Correlation of mutational analysis to clinical features in Taiwanese patients with Gilbert's syndrome.
Hsieh SY; Wu YH; Lin DY; Chu CM; Wu M; Liaw YF
Am J Gastroenterol; 2001 Apr; 96(4):1188-93. PubMed ID: 11316168
[TBL] [Abstract][Full Text] [Related]
6. Molecular genetic basis of Gilbert's syndrome.
Burchell B; Hume R
J Gastroenterol Hepatol; 1999 Oct; 14(10):960-6. PubMed ID: 10530490
[TBL] [Abstract][Full Text] [Related]
7. Frequent co-occurrence of the TATA box mutation associated with Gilbert's syndrome (UGT1A1*28) with other polymorphisms of the UDP-glucuronosyltransferase-1 locus (UGT1A6*2 and UGT1A7*3) in Caucasians and Egyptians.
Köhle C; Möhrle B; Münzel PA; Schwab M; Wernet D; Badary OA; Bock KW
Biochem Pharmacol; 2003 May; 65(9):1521-7. PubMed ID: 12732365
[TBL] [Abstract][Full Text] [Related]
8. Restriction fragment length polymorphism effectively identifies exon 1 mutation of UGT1A1 gene in patients with Gilbert's Syndrome.
Shiu TY; Huang HH; Lin HH; Shih YL; Chu HC; Chang WK; Hsieh TY
Liver Int; 2015 Aug; 35(8):2050-6. PubMed ID: 25611851
[TBL] [Abstract][Full Text] [Related]
9. Rapid molecular diagnosis of the Gilbert's syndrome-associated exon 1 mutation within the UGT1A1 gene.
Hsieh TY; Shiu TY; Chu NF; Chao TY; Chu HC; Chang WK; Chao YC; Huang HH
Genet Mol Res; 2014 Jan; 13(1):670-9. PubMed ID: 24615032
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter.
Hsieh TY; Shiu TY; Huang SM; Lin HH; Lee TC; Chen PJ; Chu HC; Chang WK; Jeng KS; Lai MM; Chao YC
Pharmacogenet Genomics; 2007 Apr; 17(4):229-36. PubMed ID: 17496722
[TBL] [Abstract][Full Text] [Related]
11. Gilbert's syndrome is not associated with HELLP syndrome.
Zusterzeel PL; te Morsche R; Raijmakers MT; Peters WH; Steegers EA
BJOG; 2001 Sep; 108(9):1003-4. PubMed ID: 11563452
[TBL] [Abstract][Full Text] [Related]
12. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn.
Monaghan G; McLellan A; McGeehan A; Li Volti S; Mollica F; Salemi I; Din Z; Cassidy A; Hume R; Burchell B
J Pediatr; 1999 Apr; 134(4):441-6. PubMed ID: 10190918
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of bilirubin uridine diphosphate-glucuronosyltransferase gene in Japanese patients with Crigler-Najjar syndrome or Gilbert's syndrome as well as in healthy Japanese subjects.
Takeuchi K; Kobayashi Y; Tamaki S; Ishihara T; Maruo Y; Araki J; Mifuji R; Itani T; Kuroda M; Sato H; Kaito M; Adachi Y
J Gastroenterol Hepatol; 2004 Sep; 19(9):1023-8. PubMed ID: 15304120
[TBL] [Abstract][Full Text] [Related]
14. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome.
Bosma PJ; Chowdhury JR; Bakker C; Gantla S; de Boer A; Oostra BA; Lindhout D; Tytgat GN; Jansen PL; Oude Elferink RP
N Engl J Med; 1995 Nov; 333(18):1171-5. PubMed ID: 7565971
[TBL] [Abstract][Full Text] [Related]
15. Dual polymorphisms in UDP-glucuronosyltransferases 1A1 and 1A6: a novel mechanism for hyperserotoninaemia in Gilbert's syndrome mimicking carcinoid syndrome?
Lee P; Jones G; Seibel MJ
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):337-40. PubMed ID: 17353700
[TBL] [Abstract][Full Text] [Related]
16. [A study of polymorphism in UDP-glucuronosyltransferase 1 (UGT-1A1) promoter gene in Korean patients with Gilbert's syndrome].
Kim YH; Yeon JE; Jung GM; Kim HJ; Kim JS; Byun KS; Bak YT; Lee CH
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):132-8. PubMed ID: 12499798
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the UDP-glucuronosyltransferase (UGT1A1) TATAA box polymorphism and carcinogen detoxification phenotype: significantly decreased glucuronidating activity against benzo(a)pyrene-7,8-dihydrodiol(-) in liver microsomes from subjects with the UGT1A1*28 variant.
Fang JL; Lazarus P
Cancer Epidemiol Biomarkers Prev; 2004 Jan; 13(1):102-9. PubMed ID: 14744740
[TBL] [Abstract][Full Text] [Related]
18. Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.
Aono S; Adachi Y; Uyama E; Yamada Y; Keino H; Nanno T; Koiwai O; Sato H
Lancet; 1995 Apr; 345(8955):958-9. PubMed ID: 7715297
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene.
Lankisch TO; Vogel A; Eilermann S; Fiebeler A; Krone B; Barut A; Manns MP; Strassburg CP
Mol Pharmacol; 2005 May; 67(5):1732-9. PubMed ID: 15716465
[TBL] [Abstract][Full Text] [Related]
20. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene.
Raijmakers MT; Jansen PL; Steegers EA; Peters WH
J Hepatol; 2000 Sep; 33(3):348-51. PubMed ID: 11019988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
